Clinical trial
NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced…
NCT00356954 · Seoul National University Hospital, Other · Completed
Key facts
| NCT number | NCT00356954 |
|---|---|
| Title | NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization |
| Official title | N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization: NASPI Study-A Randomized Controlled Trial |
| Lead sponsor | Seoul National University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Failure |
| Intervention type | Drug |
| Interventions | N-acetylcystein, ascorbic acid |
| Enrollment | 250 |
| Start date | Feb 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Jul 27, 2006 |
| Last update posted | Nov 27, 2006 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: